Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages 3811-3821

  Lopez, Ximena ^a,b,c   Cypess, Aaron ^a,b   Manning, Raquel ^a   O'Shea, Sheila ^a   Kulkarni, Rohit N ^a,b   Goldfine, Allison B ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE; HEPARIN; INSULIN; INSULIN ASPART; INTRALIPID; PROINSULIN;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; MALE; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; BLOOD GLUCOSE; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; SINGLE-BLIND METHOD;

EID: 83155165409     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0627     Document Type: Article

References (73)

1. Assmann A, Hinault C, Kulkarni RN 2009 Growth factor control of pancreatic islet regeneration and function. Pediatr Diabetes 10:14-32
2. Lingohr MK, Dickson LM, Wrede CE, McCuaig JF, Myers Jr MG, Rhodes CJ 2003 IRS-3 inhibits IRS-2-mediated signaling in pancreatic β-cells. Mol Cell Endocrinol 204:85-99 (Pubitemid 36871555)
3. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR 1999 Tissue-specific knockout of the insulin receptor in pancreatic β-cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-339 (Pubitemid 29077587)
4. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904 (Pubitemid 28157668)
5. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw 3rd EB, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ 2001 Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728-1731 (Pubitemid 32506248)
6. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Flier SN, Hanahan D, Kahn CR 1999 Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines. J Clin Invest 104:R69-R75 (Pubitemid 30053195)
7. Kaneko K, Ueki K, Takahashi N, Hashimoto S, Okamoto M, Awazawa M, Okazaki Y, Ohsugi M, Inabe K, Umehara T, Yoshida M, Kakei M, Kitamura T, Luo J, Kulkarni RN, Kahn CR, Kasai H, Cantley LC, Kadowaki T 2010 Class IA phosphatidylinositol 3-kinase in pancreatic β-cells controls insulin secretion by multiple mechanisms. Cell Metab 12:619-632
8. Aspinwall CA, Lakey JR, Kennedy RT 1999 Insulin-stimulated insulin secretion in single pancreatic β-cells. J Biol Chem 274:6360-6365 (Pubitemid 29111049)
9. Elahi D, Nagulesparan M, Hershcopf RJ, Muller DC, Tobin JD, Blix PM, Rubenstein AH, Unger RH, Andres R 1982 Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med 306:1196-1202 (Pubitemid 12158849)
10. Kraegen EW, Lazarus L, Campbell LV 1983 Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion. Metabolism 32:622-627 (Pubitemid 13099168)
11. Bouche C, Lopez X, Fleischman A, Cypess AM, O'Shea S, Stefanovski D, Bergman RN, Rogatsky E, Stein DT, Kahn CR, Kulkarni RN, Goldfine AB 2010 Insulin enhances glucose-stimulated insulin secretion in healthy humans. Proc Natl Acad Sci USA 107:4770-4775
12. Anderwald C, Tura A, Grassi A, Krebs M, Szendroedi J, Roden M, Bischof MG, Luger A, Pacini G 2011 Insulin infusion during normoglycemia modulates insulin secretion according to whole-body insulin sensitivity. Diabetes Care 34:437-441
13. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF 1999 Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055-E1066 (Pubitemid 29323421)
14. Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT 1998 Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 47:1613-1618 (Pubitemid 28445350)
15. McGuire EA, Helderman JH, Tobin JD, Andres R, Berman M 1976 Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573
16. Goldfine AB, Ebbeling CB, Ludwig DS 2002 Antegrade intravenous catheterization for metabolic studies in man. Diabetologia 45:1742-1743 (Pubitemid 35478149)
17. Rizza RA, Mandarino LJ, Gerich JE 1981 Mechanisms of insulin resistance in man. Assessment using the insulin dose-response curve in conjunction with insulin-receptor binding. Am J Med 70:169-176 (Pubitemid 11183523)
18. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223 (Pubitemid 9249478)
19. Brange J, Owens DR, Kang S, Vølund A 1990 Monomeric insulins and their experimental and clinical implications. Diabetes Care 13:923-954 (Pubitemid 20260734)
20. Gorden P, Roth J 1969 Plasma insulin: fluctuations in the "big"insulin component in man after glucose and other stimuli. J Clin Invest 48:2225-2234
21. Kahn SE, Halban PA 1997 Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725-1732 (Pubitemid 27456403)
22. Kawamori D, Kurpad AJ, Hu J, Liew CW, Shih JL, Ford EL, Herrera PL, Polonsky KS, McGuinness OP, Kulkarni RN 2009 Insulin signaling in α-cells modulates glucagon secretion in vivo. Cell Metab 9:350-361
23. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krtzfeldt J, Yin C, Holzenberger M, Stoffel M, Kulkarni RN 2007 Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 104:8977-8982 (Pubitemid 47175422)
24. Assmann A, Ueki K, Winnay JN, Kadowaki T, Kulkarni RN 2009 Glucose effects on β-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2. Mol Cell Biol 29:3219-3228
25. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM, Berggren PO 2001 Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β-cells. Mol Cell 7:559-570
26. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M 2006 Fatty acid signaling in the β-cell and insulin secretion. Diabetes 55(Suppl 2):S16-S23 (Pubitemid 44927028)
27. Best CH, Haist RE 1941 The effect of insulin administration on the insulin content of the pancreas. J Physiol 100:142-146
28. Luciani DS, Johnson JD 2005 Acute effects of insulin on β-cells from transplantable human islets. Mol Cell Endocrinol 241:88-98 (Pubitemid 41262174)
29. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR 2005 Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337-349 (Pubitemid 41127137)
30. Porzio O, Federici M, Hribal ML, Lauro D, Accili D, Lauro R, Borboni P, Sesti G 1999 The Gly972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic β-cells. J Clin Invest 104:357-364
31. Almind K, Bjørbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O 1993 Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828-832 (Pubitemid 23285910)
32. Marchetti P, Lupi R, Federici M, Marselli L, Masini M, Boggi U, Del Guerra S, Patanè G, Piro S, Anello M, Bergamini E, Purrello F, Lauro R, Mosca F, Sesti G, Del Prato S 2002 Insulin secretory function is impaired in isolated human islets carrying the Gly(972)→Arg IRS-1 polymorphism. Diabetes 51:1419-1424 (Pubitemid 34826607)
33. Leibiger B, Wahlander K, Berggren PO, Leibiger IB 2000 Glucosestimulated insulin biosynthesis depends on insulin-stimulated insulin gene transcription. J Biol Chem 275:30153-30156
34. Westerlund J, Wolf BA, Bergsten P 2002 Glucose-dependent promotion of insulin release from mouse pancreatic islets by the insulin-mimetic compound L-783,281. Diabetes 51(Suppl 1):S50-S52 (Pubitemid 34761494)
35. 2+ stores in insulin-stimulated insulin secretion in β-cells. J Biol Chem 275:22331-22338
36. Assmann A LK, Hu J, Liu S, Chakrabarti SK, Hinault C, Ueki K, Urano F, Mirmira RG, Goldfine AB, Kulkarni RN 2008 Insulin signaling regulates insulin processing in pancreatic β-cells. Diabetes 57:A64
37. Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, Perego C, Usellini L, Nano R, Bonini P, Bertuzzi F, Marlier LN, Davalli AM, Carandente O, Pontiroli AE, Melino G, Marchetti P, Lauro R, Sesti G, Folli F 2001 High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50:1290-1301 (Pubitemid 32500161)
38. Hribal ML, Perego L, Lovari S, Andreozzi F, Menghini R, Perego C, Finzi G, Usellini L, Placidi C, Capella C, Guzzi V, Lauro D, Bertuzzi F, Davalli A, Pozza G, Pontiroli A, Federici M, Lauro R, Brunetti A, Folli F, Sesti G 2003 Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN β-cell line and human islets of Langerhans. FASEB J 17:1340-1342
39. Cunningham BA, Deeney JT, Bliss CR, Corkey BE, Tornheim K 1996 Glucose-induced oscillatory insulin secretion in perifused rat pancreatic islets and clonal β-cells (HIT). Am J Physiol 271:E702-E710
40. Maki LW, Keizer J 1995 Analysis of possible mechanisms for in vitro oscillations of insulin secretion. Am J Physiol 268:C780-C791
41. Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE 2007 Progressive loss of β-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 30:677-682 (Pubitemid 46354352)
42. Ehrmann DA, Breda E, Cavaghan MK, Bajramovic S, Imperial J, Toffolo G, Cobelli C, Polonsky KS 2002 Insulin secretory responses to rising and falling glucose concentrations are delayed in subjects with impaired glucose tolerance. Diabetologia 45:509-517 (Pubitemid 34533829)
43. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA 2005 β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493-500 (Pubitemid 40116699)
44. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K 2003 A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461-2474 (Pubitemid 37210533)
45. Goh TT, Mason TM, Gupta N, So A, Lam TK, Lam L, Lewis GF, Mari A, Giacca A 2007 Lipid-induced β-cell dysfunction in vivo in models of progressive β-cell failure. Am J Physiol Endocrinol Metab 292:E549-E560 (Pubitemid 46220580)
46. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI 1996 Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865 (Pubitemid 26197099)
47. Zhou YP, Grill VE 1994 Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876 (Pubitemid 24072831)
48. Sako Y, Grill VE 1990 A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127:1580-1589 (Pubitemid 20315212)
49. Elks ML 1993 Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Endocrinology 133:208-214 (Pubitemid 23206395)
50. Hagman DK, Hays LB, Parazzoli SD, Poitout V 2005 Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J Biol Chem 280:32413-32418 (Pubitemid 41361852)
51. Rachek LI, Thornley NP, Grishko VI, LeDoux SP, Wilson GL 2006 Protection of INS-1 cells from free fatty acid-induced apoptosis by targeting hOGG1 to mitochondria. Diabetes 55:1022-1028 (Pubitemid 44100177)
52. Eitel K, Staiger H, Rieger J, Mischak H, Brandhorst H, Brendel MD, Bretzel RG, Häring HU, Kellerer M 2003 Protein kinase Cδ activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells. Diabetes 52:991-997 (Pubitemid 36384269)
53. Straub SG, Sharp GW 2004 Massive augmentation of stimulated insulin secretion induced by fatty acid-free BSA in rat pancreatic islets. Diabetes 53:3152-3158 (Pubitemid 39564490)
54. Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E 2007 Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab 292:E1775-E1781 (Pubitemid 47084713)
55. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL 1999 Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48:1836-1841 (Pubitemid 29415205)
56. Yaney GC, Corkey BE 2003 Fatty acid metabolism and insulin secretion in pancreatic β-cells. Diabetologia 46:1297-1312 (Pubitemid 37297198)
57. Fex M, Haemmerle G, Wierup N, Dekker-Nitert M, Rehn M, Ristow M, Zechner R, Sundler F, Holm C, Eliasson L, Mulder H 2009 A β-cell-specific knockout of hormone-sensitive lipase in mice results in hyperglycaemia and disruption of exocytosis. Diabetologia 52:271-280
58. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD 1996 Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735 (Pubitemid 26197087)
59. Boden G, Chen X, Iqbal N 1998 Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects. Diabetes 47:1609-1612 (Pubitemid 28445349)
60. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, D'Onofrio F 1995 Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295-1299
61. Wuesten O, Balz CH, Bretzel RG, Kloer HU, Hardt PD 2005 Effects of oral fat load on insulin output and glucose tolerance in healthy control subjects and obese patients without diabetes. Diabetes Care 28:360-365 (Pubitemid 40170940)
62. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, Uejima H, Tanaka H, Maruyama M, Satoh R, Okubo S, Kizawa H, Komatsu H, Matsumura F, Noguchi Y, Shinohara T, Hinuma S, Fujisawa Y, Fujino M 2003 Free fatty acids regulate insulin secretion from pancreatic β-cells through GPR40. Nature 422:173-176 (Pubitemid 36362750)
63. Tan CP, Feng Y, Zhou YP, Eiermann GJ, Petrov A, Zhou C, Lin S, Salituro G, Meinke P, Mosley R, Akiyama TE, Einstein M, Kumar S, Berger JP, Mills SG, Thornberry NA, Yang L, Howard AD 2008 Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice. Diabetes 57:2211-2219
64. Telvekar VN, Kundaikar HS 2008 GPR40 carboxylic acid receptor family and diabetes: a new drug target. Curr Drug Targets 9:899-910
65. Böni-Schnetzler M, Boller S, Debray S, Bouzakri K, Meier DT, Prazak R, Kerr-Conte J, Pattou F, Ehses JA, Schuit FC, Donath MY 2009 Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150:5218-5229
66. Roden M 2004 How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci 19:92-96
67. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fürnsinn C, Moser E, Waldhäusl W 1999 Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 48:358-364 (Pubitemid 29061111)
68. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, Defronzo RA, Cusi K 2005 Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54:1640-1648 (Pubitemid 40770753)
69. Mekki N, Charbonnier M, Borel P, Leonardi J, Juhel C, Portugal H, Lairon D 2002 Butter differs from olive oil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men. J Nutr 132:3642-3649 (Pubitemid 35435041)
70. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, McGarry JD 1997 The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100:398-403 (Pubitemid 27349087)
71. Samols E, Marri G, Marks V 1965 Promotion of insulin secretion by glucagon. Lancet 2:415-416
72. Shapiro ET, Tillil H, Rubenstein AH, Polonsky KS 1988 Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration. J Clin Endocrinol Metab 67:1094-1099
73. Tillil H, Shapiro ET, Rubenstein AH, Galloway JA, Polonsky KS 1988 Reduction of insulin clearance during hyperglycemic clamp. Dose-response study in normal humans. Diabetes 37:1351-1357 (Pubitemid 19035985)